Table of Contents
Mergers & Acquisitions
| Pfizer Expands Obesity Portfolio with US$4.9 B Acquisition of Metsera | Abstract pdf html |
| Shikha Kashyap |
| Roche to Acquire 89bio and its FGF21 Analogue Lead Asset for US$3.5 B | Abstract pdf html |
| Naini Anand |
| BioCryst to Acquire Astria Therapeutics for up to US$700 M | Abstract pdf html |
| Ayush Saxena |
This work is licensed under a Creative Commons Attribution 3.0 License.